Jacopo Conforti

ORCID: 0009-0004-2831-2134 · 6 papers in corpus · active 2024-2026

Study types

  • article 3
  • other 3

Condition tags

  • endometriosis 5
  • infertility 2
  • endometrioma 2
  • dysmenorrhea 1
  • die_deep_infiltrating 1
article 2026
·doi:10.1530/raf-25-0094

Abstract: Endometriosis is a chronic inflammatory disease presenting with debilitating symptoms strongly impacting patients' quality of life (QoL). Assessing QoL is crucial for understanding the full patient experience beyond clinical sympt…

other 2026
Human Reproduction ·doi:10.1093/humrep/deaf221

STUDY QUESTION: Can a serum miRNA signature serve as a potential diagnostic biomarker for endometriosis (END)? SUMMARY ANSWER: A miRNA-based diagnostic model demonstrated an accuracy of 65.8% in distinguishing END patients from control sub…

other 2025
Biomedicines ·doi:10.3390/biomedicines13102381

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medica…

other 2025
Clinical case reports ·doi:10.1002/ccr3.71335

Primary presacral clear cell carcinoma (CCC) of Müllerian origin is extremely rare. Malignant transformation of endometriosis is a known phenomenon, though typically involving the ovaries or pelvic peritoneum. Retroperitoneal presentation, …

article 2025
·doi:10.23736/s0393-0564.25.00034-2

INTRODUCTION: Endometriosis (END) is a debilitating gynecological disorder. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. The discovery of non-invasive biomarkers is necessary to overcome the disa…

article 2024
Women's health (London, England) ·doi:10.1177/17455057241252573

BACKGROUND: Almost 10% of women in reproductive age are diagnosed with ovarian endometriomas and can experience symptoms and infertility disorders. Ovarian endometriomas can be treated with medical or surgical therapy. OBJECTIVE: To assess …